Rakugi H, Shimizu K, Nishiyama Y, et al. (2017). A phase III, open-label, multicenter study to evaluate the safety and efficacy of long-term triple combination therapy with azilsartan, amlodipine, and hydrochlorothiazide in patients with essential hypertension. Blood Pressure. http://dx.doi.org/10.1080/08037051.2017.1412797.
When the above article was first published online, the acknowledgement section was missing some data. This has now been corrected in both the print and online versions.
Taylor & Francis apologises for this error.